未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
L-Type amino acid transporter 1-targeting nanoparticles for antisense oligonucleotide delivery to the CNS Lim, Yu Na; Ryu, In Soo; Jung, Yeon-Joo; Helmlinger, Gabriel; Kim, Insun; Park, Hye Won; Kang, Hansol; Lee, Jina; Lee, Hyo Jin; Lee, Kang Seon; Jang, Ha-Na; Ha, Dae-In; Park, Junghyung; Won, Jinyoung; Lim, Kyung Seob; Jeon, Chang-Yeop; Cho, Hyun-Jeong; Min, Hyun Su; Ryu, Jin-Hyeob 分享 收藏
分享 收藏
Implantable Intraocular Fluorescence Sensor for Visualized Monitoring of Alzheimer's Disease Lim, Jaewook; Lee, Hyo; Kim, Jiwon; Moon, Chae-Eun; Lee, Jun-Ki; Kang, Yujin; Kim, Ryunhyung; Mun, Byeonggeol; Ji, Yong Woo; Haam, Seungjoo 分享 收藏
Spatial Analysis of Tumor-Infiltrating Lymphocytes in mRCC Patients Treated with Pexa-Vec (Thymidine Kinase-Deactivated Vaccinia Virus plus GM-CSF) and cemiplimab (REGN2810; Anti-PD-1) Rha, S. Y.; Bae, W. K.; Kim, C.; Ma, S.; Oh, S. Y.; Lee, H. J.; Park, K.; Mar, N.; Pachynski, R.; Mathias, M.; Seebach, F.; Folefac, E.; Beom, S. H.; Carranza, L.; Merchan, J. R. 分享 收藏
Triglyceride-glucose index and risk of cardiovascular events, renal allograft loss, and new onset diabetes after transplantation in renal transplant recipients. Lee, Yu Ho; Lee, Hyo Jin; Kim, Jin Sug; Jeong, Kyung Hwan; Yoon, Soo-Young; Kim, Dae Kyu; Lee, Jeong-Yeun; Kim, Hyun Kyu; Yoon, Hye Eun; Na, Ki-Ryang; Lee, Dong Ryeol; Yang, Jaeseok; Kim, Myoung Soo; Hwang, Hyeon Seok 分享 收藏
Real-world outcomes of third-line immune checkpoint inhibitors versus irinotecan-based chemotherapy in patients with advanced gastric cancer: a Korean, multicenter study (KCSG ST22-06) 在晚期胃癌患者中,三线免疫检查点抑制剂与基于伊立替康的化疗的真实世界结果: 韩国多中心研究 (KCSG ST22-06) Lim, Sung Hee; Lee, Keun-Wook; Kim, Jae-Joon; Im, Hyeon-Su; Kim, In-Ho; Han, Hye Sook; Koo, Dong-Hoe; Cho, Jang Ho; Maeng, Chi Hoon; Lee, Min-Young; Lee, Hyo Jin; Kim, Jwa Hoon; Park, Sang Gon; Jung, Joo Young; Shin, Seong-Hoon; Kim, Ki Hyang; Kim, Hyeyeong; Oh, So Yeon; Kang, Minsu; Jung, Minkyu; Rha, Sun Young 分享 收藏
FGFR inhibition augments anti-PD-1 efficacy in murine FGFR3-mutant bladder cancer by abrogating immunosuppression Okato, Atsushi; Utsumi, Takanobu; Ranieri, Michela; Zheng, Xingnan; Zhou, Mi; Pereira, Luiza D.; Chen, Ting; Kita, Yuki; Wu, Di; Hyun, Hyesun; Lee, Hyojin; Gdowski, Andrew S.; Raupp, John D.; Clark-Garvey, Sean; Manocha, Ujjawal; Chafitz, Alison; Sherman, Fiona; Stephens, Janaye; Rose, Tracy L.; Milowsky, Matthew I.; Wobker, Sara E.; Serody, Jonathan S.; Damrauer, Jeffrey S.; Wong, Kwok-Kin; Kim, William Y. 分享 收藏
分享 收藏
Outcomes by retrospective eligibility for maintenance therapy of patients (pts) with advanced urothelial carcinoma (UC): Post hoc analysis of KEYNOTE-361 Mamtani, R.; Matsubara, N.; Montesa Pino, A.; Anido Herranz, U.; Sendur, M. A. N.; Gravis, G.; Huillard, O.; Lee, H. J.; Gafanov, R.; Lobbedez, F. Joly; Bedke, J.; Sella, A.; Chang, Y. H.; Imai, K.; Moreno, B. Homet; Xu, J.; Alva, A.; Powles, T. B. 分享 收藏